A fund advised by SHS Gesellschaft für Beteiligungsmanagement mbH, has acquired puracon's business operations from the insolvent predecessor company.
Based in Rosenheim, puracon is a packaging specialist focused on the sterile assembly and packaging of medical devices and implants in GMP certified cleanrooms. The range of services that it provides its globally active customers also includes consultancy with regard to all regulatory issues as well as conducting the required testing, certification and validation in compliance with the respective national directives. Puracon realigned its business in light of increasingly stringent regulatory requirements in 2013/2014.
"With its business model, Puracon is active in a fast-growing market driven by the increasing number of regulatory restrictions being imposed by legislators. We will assist puracon in its expansion – especially internationally – so that the company can establish itself even more solidly in the future as a market leader in a dynamic environment,” says Uwe Steinbacher, Managing Partner at SHS.
"We are glad to have found a new owner for puracon in the experienced medical technology investor SHS, which will accompany the company’s continued growth, stand for stability and continuity and thus offer exceptional perspectives for our customers as well,” explains Sascha Kocis, Member of the Board at puracon.
With its acquisition of puracon, SHS is further pursuing its stated investment strategy. With a fund volume of 125 million euro, SHS is currently focusing its investment on expansion financing, changes in shareholder structures and successor situations. The Tübingen based investor is planning further acquisitions and investments in the fast-growing medical technology and life-science industries in the months ahead.
